Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Sahasrabudhe, M. Joshi, V. Oswal (Pimpri, Pune, India). Patterns of bronchodilator reversibility of FEV1 in asthma and COPD patients. Eur Respir J 2012; 40: Suppl. 56, 2196

Member's Comments

No comment yet.

Related content which might interest you: Assessing bronchodilator response in patients with asthma and COPD using 19F-MRI Source: Virtual Congress 2020 – New imaging techniques applied to old problems Year: 2020 Evaluation of the response of airway obstruction to short-acting inhaled broncodilators with using FIV1 and FEV1 in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 290s Year: 2005 Bronchodilator reversibility - differences between asthma and COPD Source: International Congress 2019 – Respiratory function assessment in disease Year: 2019 Tiotropium: COPD exacerbations and decline in FEV1 Source: Eur Respir J 2001; 18: Suppl. 33, 486s Year: 2001 Reducing the decline of FEV1 after a 4-year therapy with montelukast in patients with bronchial asthma Source: Annual Congress 2008 - Recent advances in the pathogenesis and treatment of asthma and COPD Year: 2008 Bronchodilator treatment for asthma and COPD Source: Annual Congress 2010 - Bronchodilator treatment for asthma and COPD Year: 2010 How the bronchodilatator in COPD patients works Source: Eur Respir J 2004; 24: Suppl. 48, 288s Year: 2004 Closing volume predicts the FEV1 response to bronchodilators in patients with COPD Source: Virtual Congress 2020 – Advances in lung function testing Year: 2020 FEV1 and MRI ventilation defect reversibility in asthma and COPD Source: Eur Respir J, 55 (3) 1901947; 10.1183/13993003.01947-2019 Year: 2020 Does an acute FEV1 response predict long-term improvements with bronchodilators in patients with COPD? Source: Eur Respir J 2001; 18: Suppl. 33, 486s Year: 2001 sGaw as an alternative for FEV1 in the measurement of airway responsiveness to methacholine in patients experiencing chronic cough Source: Annual Congress 2011 - Lung function today and tomorrow I Year: 2011 Comparison of spirometric z-scores with FEV1 percent prediction in predicting exacerbations in elderly COPD patients Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016 Bronchodilator responsiveness in patients with COPD Source: Eur Respir J 2008; 31: 742-750 Year: 2008 Influence of basal FEV1 on the response to bronchodilator agents in COPD Source: Eur Respir J 2001; 18: Suppl. 33, 426s Year: 2001 Decline in FEV1 is faster with frequent exacerbations of COPD Source: Eur Respir J 2001; 18: Suppl. 33, 153s Year: 2001 Severe exacerbations, decline in lung function and inhaled budesonide in asthma Source: Eur Respir J 2007; 30: Suppl. 51, 619s Year: 2007 Evaluation of the individual bronchodilator response in patients with severe COPD Source: Eur Respir J 2002; 20: Suppl. 38, 246s Year: 2002 Immediate bronchodilator response in FEV1 as a diagnostic criterion for adult asthma Source: Eur Respir J, 53 (2) 1800904; 10.1183/13993003.00904-2018 Year: 2019 The effect of tiotropium on exacerbations and airflow in patients with COPD Source: Eur Respir J 2006; 27: 547-555 Year: 2006 Bronchodilator efficacy of tiotropium in patients with mild COPD Source: Eur Respir J 2006; 28: Suppl. 50, 616s Year: 2006